MedTrace Logo

Noninvasive Respiratory Support in COVID-19 (CATCOVID-AIR)

NCT04668196 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 367

Last updated 2021-04-13

No results posted yet for this study

Summary

COVID-19 pneumonia can cause severe acute hypoxemic respiratory failure. The usefulness of noninvasive respiratory support (NIRS), by means of nasal high-flow oxygen (NHFO), continuous positive airway pressure (CPAP), or noninvasive ventilation (NIV), established outside the intensive care unit, is unknown. The aim of this multicenter, retrospective, longitudinal study is to compare the effectiveness of these treatments to prevent death or endotracheal intubation at day 28, and what factors, related to the disease or to the characteristics of the treatment itself, can condition its success or failure.

Conditions

  • Covid19
  • Acute Respiratory Failure
  • Corona Virus Infection

Interventions

DEVICE

High-flow nasal cannula treatment

Standard operating procedures represented by hihg-flow nasal cannula oxygen therapy

DEVICE

Continuous positive airway pressure (CPAP) treatment

Standard operating procedures represented by continuous positive airway pressure (CPAP) therapy

DEVICE

Noninvasive ventilation treatment

Standard operating procedures represented by noninvasive ventilation treatment

Sponsors & Collaborators

  • Barcelona Institute for Global Health

    collaborator OTHER

  • Hospital Universitari Vall d'Hebron Research Institute

    lead OTHER

Principal Investigators

  • Júlia Sampol, MD · Hospital Universitari Vall d'Hebron Research Institute

  • Sergi Marti, MD PhD · Hospital Universitari Vall d'Hebron Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-22
Primary Completion
2021-01-25
Completion
2021-01-25

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04668196 on ClinicalTrials.gov